Egerup, Pia http://orcid.org/0000-0002-8047-2459
Mikkelsen, Anders P.
Kolte, Astrid Marie
Westergaard, David
Rasmussen, Steen
Knop, Filip K.
Lidegaard, Øjvind
Nielsen, Henriette S.
Funding for this research was provided by:
Nove Nordisk Foundation (NNF18SA0034956)
Ole Kirks Foundation
Article History
Received: 28 October 2019
Accepted: 10 March 2020
First Online: 20 May 2020
Author’s relationships and activities
: AMK has received speaker’s fees from Merck Denmark A/S. HSN has served on the scientific advisory board for Ferring Pharmaceuticals and received speaker’s fees from Ferring Pharmaceuticals, Merck Denmark A/S and Ibsa Nordic. FKK has served on scientific advisory panels and/or been part of speakers bureaus for, served as a consultant to and/or received research support from Amgen, AstraZeneca, Bayer, Boehringer Ingelheim, Carmot Therapeutics, Eli Lilly, Gubra, MedImmune, MSD/Merck, Mundipharma, Norgine, Novo Nordisk, Sanofi and Zealand Pharma. PE, APM, SR, DW and ØL declare that there are no relationships or activities that might bias, or be perceived to bias, their work.
Free to read: This content has been made available to all.